CXCL10 and Lymphadenopathy: An apparent increase in IP-10 levels were also seen in one of the EPTB patients who experienced paradoxical lymphadenopathy during therapy, whereas patients with disseminated and resistant TB responded with decline in IP-10 levels corresponding to clinical improvements.